Pharmaniaga records 3Q net profit of RM49.84mil on soaring revenue


KUALA LUMPUR: Pharmaniaga Bhd recorded a net profit of RM49.84mil in the third quarter ended Sept 30, 2021, as compared to just RM1.44mil in the previous corresponding quarter following a jump in group revenue, driven by sales of the Sinovac Covid-19 vaccine.

The pharmaceuticals group reported earnings per share of 3.81 sen compared to 0.11 sen in 3QFY20.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Pharmaniaga , Sinovac , vaccine , pharmaceuticals

   

Next In Business News

Shell says it remains committed to mobility business in Malaysia
Federal Court rules in SC’s favour, Ricky Wong’s leave application dismissed
Regional expansion to bode well for CTOS
Miti: Semiconductor industry offers Malaysia chance for exponential growth
Ringgit slightly higher at the close
Awantec to strengthen its synergistic offerings to drive growth
Bursa Malaysia hits all-time high market capitalisation of more than RM2 trillion
Sapura Energy gets US$1.8bil worth of PLSV-related contracts
OCK enters tower leasing agreement, marks debut into Laos
AmBank, CGC announce additional RM400mil under the SME Portfolio Guarantee Scheme

Others Also Read